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The first shunts being successfully used for the treat-
ment of hydrocephalus were designed to lower an over-
pressure within the ventricles of the brain. Later the
same technology was used for the treatment of normal
pressure hydrocephalus, although the background of this
disease can not be compared with obstructive hydroce-
phalus. Since then no specific device has been developed
focussing on the treatment of NPH. However, the recent
knowledge of NPH and the risks behind the shunting of
NPH offer interesting options.
For the diagnosis of NPH an often used method is the
spinal tap test. The withdrawal of up to 50 cc of spinal
fluid sometime leeds to impressive clinical improvement.
To address this fact a new device has been developed
which can be programmed to open depending on time
and body position. Consequently in contrast to valves for
the treatment of obstructive hydrocephalus this device
does not open depending on increased baseline ICP or
ICP peaks. The device can be programmed to open for
two minutes intervals over 24 hours. The valve can be
programmed to remain closed, to open for two minutes
within 24 hours, to open the whole 24 hours or any time
between two minutes and 24 hours. In addition it can
be programmed whether or not the opening should be
manipulated by the body position of the patient in parti-
cular to allow an only reduced flow in the standing
position.
The new electronic device is the first implant developed
only for NPH addressing specific aspects of this decease.
The valve has been investigated in vitro simulating the
condition within a patient. It has not been implanted yet,
because of regulatory issues. Whether or not the device
improved the clinical outcome in patients with NPH,
whether or not it can lower risks for these patients and
introduce new treatment options can not be answered
without clinical experience. However, it promises to be a
tool for scientific research, which might help to improve
the understanding of NPH.
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